Compass Points

Maintaining Quality of Life in Multiple Sclerosis: Multidisciplinary Rehabilitation and Improving the Physician-Patient Relationship

Multiple sclerosis (MS) is a neurodegenerative disease characterized by slow, progressive decline with effects on mobility, cognition, and overall quality of life (QoL). As there is no cure for MS, disease management focuses on inhibiting disease progression and treating symptoms. However, factors such as rehabilitation and the patient-provider relationship can also influence QoL...

> Read more (Earn up to 0.5 AMA PRA Category 1 Credit(s)™)
> Back to top

Compass Questions™

> Back to top

Responses from Last Compass Questions™

In the 10.19.10 issue of Clinical Compass™, we asked six questions.

Question #1 was "BEFORE reading this article, how often DID you screen your grieving patients for major depression by asking at least two questions about mood and anhedonia?" and the neuroscienceCME learning community responded:
48.4% - Always
25.8% - Often
12.9% - Sometimes
6.5% - Rarely
3.2% - Never
3.2% - N/A - This is not my role

Question #2 was "NOW that you have read this article, how often WILL you screen your grieving patients for major depression by asking at least two questions about mood and anhedonia?" and the neuroscienceCME learning community responded:
77.7% - Always
16.1% - Often
3.2% - Sometimes
0.0% - Rarely
0.0% - Never
3.2% - N/A - This is not my role

Question #3 was "BEFORE reading this article, how often DID you monitor grieving patients for major depression by periodically asking at least two questions about mood and anhedonia or administering a validated depression screening tool?" and the neuroscienceCME learning community responded:
41.9% - Always
29.0% - Often
22.6% - Sometimes
3.2% - Rarely
0.0% - Never
3.2% - N/A - This is not my role

Question #4 was "NOW that you have read this article, how often WILL you monitor grieving patients for major depression by periodically asking at least two questions about mood and anhedonia or administering a validated depression screening tool?" and the neuroscienceCME learning community responded:
64.5% - Always
22.6% - Often
6.5% - Sometimes
0.0% - Rarely
0.0% - Never
6.5% - N/A - This is not my role

Question #5 was "As a result of my participation in this activity, I will use the differential diagnosis of normal grief, prolonged grief, and major depressive episode (MDE) and be able to explain which symptoms allow the diagnosis of MDE even before 2 months since loss have elapsed." and the neuroscienceCME learning community responded:
61.3% - Definitely
32.3% - Yes
3.2% - Probably
0.0% - Probably not
0.0% - No
3.2% - N/A - This is not my role

Question #6 was "The 9-question Patient Health Questionnaire is available free online at http://www.depression-primarycare.org/clinicians/ toolkits/materials/forms/phq9/ questionnaire_sample. Will you visit this site and become familiar with its questions, especially the first two?" and the neuroscienceCME learning community responded:
61.3% - Definitely
19.4% - Yes
16.1% - Probably
0.0% - Probably not
3.2% - No
0.0% - N/A - This is not my role

> Back to top

neuroscienceCME Live and On Demand
Premieres TOMORROW!

Early Identification, Intervention, and Quality Care in Schizophrenia: Bringing Together Community, Family, and Physicians

Premiere Date: Wednesday, November 3, 2010
Live Broadcast: 12:00-1:00 p.m. ET

"After the Show" live Q&A webcast: 1:02 p.m. ET
Taped Re-Air: 4:00–5:00 p.m. ET

> View activity details
> Add to calendar

Take Our Viewer Poll

CME Outfitters and the faculty would like to take the pulse of the neuroscienceCME community related to educational concepts that will be addressed in this live activity. This new polling feature is the first of many to come on neuroscienceCME.com, so we encourage you to take advantage of it. Submit your opinion, find out how your peers responded, and see the results discussed live on November 3!

> View poll

Statement of Need
Schizophrenia is a disease that begins in early adulthood and places a significant burden on the family and on society. Early identification and treatment that involves collaboration among families, care providers, and the community have been shown to be effective...

> Read more

Activity Goal
To provide clinicians with an update on the best practices for identifying and managing individuals with schizophrenia utilizing a multimodal treatment plan which includes medication, adherence to treatment, psychosocial interventions, and the involvement of family and other significant people in a patient's care.

Credit Information
This activity offers CE credit for:

• Physicians (CME)
• Nurses (CNE)
• Pharmacists (ACPE)
• Psychologists (APA)
• Social Workers (NASW)
• Certified Case Managers (CCMC)

All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.

> Back to top